Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival. | Clin Lung Cancer | 2022 | 35739016 | PubTator, text mining | PubMed |
| Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias. | Front Pharmacol | 2022 | 35734412 | PubTator, text mining | PubMed |
| The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. | PLoS Pathog | 2022 | 35731833 | PubTator, text mining | PubMed |
| Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study. | Int J Cancer | 2022 | 35723131 | PubTator, text mining | PubMed |
| Splice site proximity influences alternative exon definition. | RNA Biol | 2022 | 35723015 | PubTator, text mining | PubMed |
| A Unifying Perspective on Perception and Cognition Through Linguistic Representations of Emotion. | Front Psychol | 2022 | 35712179 | PubTator, text mining | PubMed |
| Hsa_circ_0008726 regulates the proliferation, migration, and invasion of trophoblast cells in preeclampsia through modulating the miR-1290-LHX6 signaling pathway. | J Clin Lab Anal | 2022 | 35698314 | PubTator, text mining | PubMed |
| Antiretroviral therapy restores the homeostatic state of microglia in SIV-infected rhesus macaques. | J Leukoc Biol | 2022 | 35686500 | PubTator, text mining | PubMed |
| Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism. | Mol Cancer Res | 2022 | 35675041 | PubTator, text mining | PubMed |
| Leveraging Deep Learning Techniques and Integrated Omics Data for Tailored Treatment of Breast Cancer. | J Pers Med | 2022 | 35629097 | PubTator, text mining | PubMed |
| RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. | Cancers (Basel) | 2022 | 35626096 | PubTator, text mining | PubMed |
| Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells. | Cancers (Basel) | 2022 | 35625986 | PubTator, text mining | PubMed |
| Dysregulation and therapeutic targeting of RNA splicing in cancer. | Nat Cancer | 2022 | 35624337 | PubTator, text mining | PubMed |
| The significance of the fusion partner gene genomic neighborhood analysis in translocation-defined tumors. | Mol Genet Genomic Med | 2022 | 35621010 | PubTator, text mining | PubMed |
| New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2. | World J Clin Oncol | 2022 | 35582653 | PubTator, text mining | PubMed |
| Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression. | J Biol Chem | 2022 | 35569509 | PubTator, text mining | PubMed |
| Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models. | Cancers (Basel) | 2022 | 35565254 | PubTator, text mining | PubMed |
| Characterization of a Cutibacterium acnes Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation. | Int J Mol Sci | 2022 | 35563458 | PubTator, text mining | PubMed |
| Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications. | Int J Mol Sci | 2022 | 35562964 | PubTator, text mining | PubMed |
| Helicobacter pylori Infection Mediates Inflammation and Tumorigenesis-Associated Genes Through miR-155-5p: An Integrative Omics and Bioinformatics-Based Investigation. | Curr Microbiol | 2022 | 35551487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=17